Tegla et al. observed that the expression of SIRT1 was significantly increased in both acute and chronic active lesions in MS brains and peripheral blood mononuclear cells when obtained from patients with RRMS [34]. This evidence concerns the gene SIRT1 and myeloid sarcoma.